[PERSON]
Kyle Diamantas
Featured in 8 tracked stories · first seen
Situations
FDA approves Rasonque; EMA recommends for pancreatic cancer
44 clusters · 321 sources · last updated
Latest: Pancreatic cancer: New research and treatment developments in Greece
On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R
FDA rare disease drug development reform
3 clusters · 10 sources · last updated
Latest: FDA launches initiative to standardize rare disease drug reviews
The U.S. Food and Drug Administration (FDA) has launched the ‘Rare Disease Framework Initiative’ to redesign the development and review process for drugs and biologics targeting rare conditions. The initiative seeks to m
US legislative efforts regarding mifepristone
2 clusters · 4 sources · last updated
Latest: U.S. lawmakers demand FDA updates on mifepristone safety study
In late September 2026, Senator Josh Hawley introduced the ‘Safeguarding Women from Chemical Abortion Act,’ calling for a congressional ban on the abortion medication mifepristone. Hawley argued the drug is unsafe for bo
Also covered in
-
FDA approves first generic weekly hormone therapy patch
[HEALTH] · 2 sources ·
-
FDA updates terminology to clarify animal testing is not required for all drugs
[HEALTH] · 3 sources ·
-
FDA seeks public input on regulating generative AI medical devices
[HEALTH] · 2 sources ·